Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

The need to seek improved combined oral contraceptive (COC) efficacy, with fewer health
risks and better acceptability, has been ongoing since the introduction of COCs more than …

Objective To assess the effect on hemostasis parameters of a new combined oral
contraceptive (COC). Study design In this randomized, single centre, open-label, exploratory …

Objective To assess and compare the risk of venous thromboembolism (VTE) and arterial
thromboembolism (ATE) in NOMAC-E2 users with levonorgestrel-containing combined oral …

Introduction The increased risk of venous thromboembolism associated with the use of
hormonal contraception is well recognized, but evidence regarding hormonal contraception …

Objective To compare the impact on thrombin generation of the new combined oral
contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or …

Objectives To compare the effects of a combined oral contraceptive (COC) containing
nomegestrol acetate and 17β-oestradiol (NOMAC/E2) on haemostasis, lipids, carbohydrate …

The debate about contraception has become increasingly important as more and more
people seek safe and effective contraception. More than 1 billion women of reproductive age …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

Abstract Background and Objective: The hormonal components of combined oral
contraceptives (COCs) have various metabolic and haemostatic effects. The objective of this …